How to Buy Atrium Therapeutics Stock

Atrium Therapeutics Inc

Avidity Biosciences, Inc. , a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases.

Atrium Therapeutics stock last closed at $13.79, up 0.29% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Atrium Therapeutics stock is currently +5.59% from its 52-week low of $13.06, and -17.77% from its 52-week high of $16.77.

How to Buy Atrium Therapeutics Stock

Not sure how to invest in Atrium Therapeutics stock? Here's how.

  1. Choose where to buy Atrium Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you choose where to buy Atrium Therapeutics stock.
  2. Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Deposit money your investment account: Choose your method of payment and add your info.
  4. Research Atrium Therapeutics stock: The Atrium Therapeutics ticker symbol is RNA. Is Atrium Therapeutics stock a good investment? Should you buy shares of RNA? How do RNA's underlying business fundamentals look? Do top analysts think Atrium Therapeutics is a good buy? Why has RNA's stock price moved recently? (Hint: Our stock research tools can help you decide if RNA is a good stock to buy).
  5. Make your RNA buy order: Decide if you will purchase RNA shares at the current market price or use a limit order to buy RNA shares at a given price.
  6. Track your RNA position: Create a watchlist to track your new investment in Atrium Therapeutics shares.

Step 1: Choose where to buy Atrium Therapeutics stock

You need an online brokerage account in order to access the NASDAQ market and buy RNA stock.

A brokerage account is an investment account that allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our experience, eToro is the best place to buy stocks. eToro gives you:

  • Invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to world financial markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've chosen your brokerage, the next step is to fill out some personal information so you can buy RNA stock today.

How to Create a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal details to create a new trading account.
  1. Send your info by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your investment account

Now that you've finished signing up on the best stock broker app, your next step is to transfer the money for your investment:

Watch the walkthrough below for more details transferring money into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Atrium Therapeutics stock

After you have decided on the best place to buy Atrium Therapeutics stock, it's crucial to research their stock before you buy, so you can comprehend the risk as well as the upside.

Atrium Therapeutics Numbers

RNA Price
$13.79
1w %
-6.76%
1y %
N/A
5y %
N/A
P/E
N/A
P/B
N/A
P/S
11.49x
PEG
N/A
Revenue
$18.62M
Earnings
-$49.50M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
N/A
Next Earnings
May 12, 2026
Next Dividend
N/A

Fundamentals of RNA

WallStreetZen was created to help average investors perform more accurate fundamental analysis quickly.

You can see all of the due diligence checks on RNA's stock page.

How is RNA stock valued?

Investors use many financial metrics, analyses, models, and charts to gauge RNA's fair value.

You can do additional valuation analysis on RNA's stock here.

A look at RNA Cashflows and Balance Sheet

Signs that RNA is not financially healthy:

  • RNA has $0.00 in cash and short term investments. This is not sufficient to cover its annual cash burn of $42.57M.
  • RNA has cash burn of 42574000. It does not have enough cash and short-term investments to cover this.
  • Total RNA debt is still negative.
  • There are more short-term liabilities than short-term assets on the RNA balance sheet.
  • RNA profit margin has gone down from -230.5% to -265.9% in the past year.
  • There are more long-term liabilities than short-term assets on the RNA balance sheet.
  • RNA debt to equity ratio of -1.13 is negative.

Is Atrium Therapeutics stock a Buy, Hold, or Sell, according to analysts?

Out of 1 Wall Street analysts who monitor RNA, the consensus analyst rating on Atrium Therapeutics is a Strong Buy

Please note that analyst forecasts are not stock recommendations, nor are they financial advice.

You can dive deeper into what analysts are saying on the Atrium Therapeutics stock forecast page.

RNA Trading Indicators

SMA10
14.88
SMA20
N/A
SMA50
N/A
SMA100
N/A
SMA200
N/A
MACD
N/A
MACD Signal
N/A
MACD Histogram
N/A
RSI
N/A
Stochastic %K
N/A
Stochastic %D
N/A
StochRSI %K
N/A
StochRSI %D
N/A

Is RNA Making Money?

Last year, RNA revenue was $18.62M. In the last 2 year, RNA's revenue has increased by 38.09% per year. This was faster than the Biotechnology industry average of 29.11%.

Dig into RNA's earnings and revenue performance here.

What are RNA executives and large shareholders up to?

In the last 12 months, insiders at RNA have not bought or sold any shares.

Research more about who owns RNA stock here.

Does RNA provide a stable income stream?

No, Atrium Therapeutics doesn't provide an income stream by paying out dividends.

What others are saying about RNA

One of the reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Make your RNA buy order

You have two main types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are usually sufficient.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to be certain you're buying or selling at a particular dollar amount limit, place a limit order.

Hit the Open Trade button and eToro will execute the order.

If you require more help with investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Track your RNA position

Now that you own some RNA stock, you'll want to stay up-to-date on your investment.

Add RNA to a watchlist to keep tabs on your RNA stock.

RNA Feed

How to Buy Stock in Atrium Therapeutics

To reiterate, here are the 6 steps to buy stock in Atrium Therapeutics:

  1. Choose where to buy Atrium Therapeutics stock
  2. Create a brokerage account
  3. Deposit money your investment account
  4. Research Atrium Therapeutics stock
  5. Make your RNA buy order
  6. Track your RNA position

If you are looking for a place to buy stocks, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep an eye on your new investment in Atrium Therapeutics, create your watchlist below.

NASDAQ: RNA
$13.79+0.04 (+0.29%)
Updated Mar 16, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: RNA
$13.79+0.04 (+0.29%)
Updated Mar 16, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Atrium Therapeutics share?

As of Mar 16, 2026, it costs $13.79 to buy one share of Atrium Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $6, you can buy 0.435 shares of RNA.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Atrium Therapeutics stock?

According to 1 Wall Street analysts who monitor Atrium Therapeutics, their consensus recommendation is to buy Atrium Therapeutics stock.

What is the best way to buy Atrium Therapeutics stock?

One way to place an order for Atrium Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.